The Quest Diagnostics white paper, "Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing", offers an in-depth analysis of the current state of rare disease ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

Grail has partnered with Quest Diagnostics to enable ... at an elevated risk of cancer. The test has yet to receive approval from the US Food and Drug Administration but it is regulated under ...

Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.

Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire ...

Healthcare diagnostics company Quest Diagnostics (NYSE ... as well as genetic testing and drug monitoring services. The testing and diagnostics services industry plays a crucial role in disease ...